Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Red Sage (Salvia miltiorrhiza) and Circulation Support: Evidence Overview

Red Sage, also known as Danshen, has a long history of use in Traditional Chinese Medicine (TCM) for cardiovascular and circulatory disorders. In recent decades, its effects have been increasingly studied in scientific research, particularly for its impact on blood flow and vascular health.

Phytochemical analysis of Red Sage reveals the presence of active components such as tanshinones and salvianolic acids, which have been shown to exhibit antioxidant, anti-inflammatory, and vasodilatory properties. Several preclinical studies and clinical trials suggest that Red Sage extracts may improve microcirculation, reduce blood viscosity, inhibit platelet aggregation, and promote endothelial function. For example, a 2018 systematic review in the journal Phytomedicine concluded that Danshen preparations showed efficacy in improving symptoms and biomarkers in patients with chronic circulatory conditions, such as angina pectoris and peripheral arterial disease. Additionally, some studies have reported that Red Sage can enhance recovery from ischemic events by promoting blood flow and reducing tissue damage.

Despite these promising findings, many clinical trials have methodological limitations, including small sample sizes and variability in extract standardization. However, the convergence of traditional use and accumulating scientific evidence supports Red Sage’s role in addressing poor circulation. Overall, the evidence justifies a relatively high confidence rating, although more rigorous, large-scale human trials are still warranted.

More about Red Sage
More about Circulation (poor)

Other ingredients used for Circulation (poor)

Other health conditions supported by Red Sage

Products containing Red Sage